Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tongue Conservation Surgery with Induction Chemotherapy for Advanced Oral Tongue Cancer
NCT03161548Phase 2Terminated
- Sponsor
- Taipei Veterans General Hospital
- Start
- Jul 2011
- Primary completion
- Jan 2016
- Modality
- Nanoparticles, Small Molecules
01
Overview
Phase 2, open-label, single-arm trial of docetaxel, Cisplatin micelle injection (HA132) and tegafur + uracil in oral tongue cancer, sponsored by Taipei Veterans General Hospital. Primary endpoint: Objective Response Rate. Started Jul 2011; status: terminated.
02
Drugs
docetaxelCisplatin micelle injection (HA132)tegafur + uracil
03
Conditions
oral tongue cancer
Beyond the preview
Go deeper on NCT03161548.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03161548.